Loss of p53 epigenetically modulates epithelial to mesenchymal transition in colorectal cancer
Shreya Sharma(Institute of Bioinformatics and Applied Biotechnology), Vijayalakshmi Mahadevan(Institute of Bioinformatics and Applied Biotechnology)
Cited by 17
Related Papers
ATRT-38. TAK228 COMBINES WITH NAVITOCLAX TO ENHANCE PLATINUM-INDUCED CYTOTOXICITY IN AT/RT
|Neuro-Oncology|2018|0
Loss of tumour suppressor p53 rewires enhancer landscape and governs oncogenic progression
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0